Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
Massachusetts General Hospital · with National Cancer Institute (NCI) · NCT05524428
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 2
- US sites recruiting
- 4
- Study start
- March 24, 2023
- Record last updated
- November 14, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
Being studied: Implementation Science Strategy
Conditions: Colo-rectal Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Staff members at partnering sites (see locations) who are administrative leaders, population health managers, data analysts, quality improvement staff, nurses, nurse managers, practice managers, medical assistants, and providers.
- Staff members at partnering sites ages 18+.
Exclusion Criteria
- Staff members that are not involved in CRC screening practices at CHCs.
Recruiting US locations
Codman Square Health Center
Boston, MA 02124
Site contact: Stephen Tringale, MD
Brockton Neighborhood Health Center
Brockton, MA 02301
Site contact: Madhur Kuckreja, MD
East Boston Neighborhood Health Center
East Boston, MA 02128
Site contact: Heidi Emerson, PhD
Duffy Health Center
Hyannis, MA 02601
Site contact: Lisa Jones, MD
Study contacts (from the official record)
- Adjoa Anyane-Yeboa, MD, MPH · 617-726-2426 · aanyane-yeboa@mgh.harvard.edu
- Nathan Yoguez, MPH · nyoguez@mgh.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+